Resolvins
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Aspirin (ASA) is unique among current therapies because it acetylates cyclooxygenase (COX)-2 enabling the biosynthesis of R-containing precursors of endogenous antiinflammatory mediators. Here, we report that lipidomic analysis of exudates obtained in the resolution phase from mice treated with ASA and docosahexaenoic acid (DHA) (C22:6) produce a novel family of bioactive 17R-hydroxy-containing di- and tri-hydroxy-docosanoids termed resolvins. Murine brain treated with aspirin produced endogenous 17R-hydroxydocosahexaenoic acid as did human microglial cells. Human COX-2 converted DHA to 13-hydroxy-DHA that switched with ASA to 17R-HDHA that also proved a major route in hypoxic endothelial cells. Human neutrophils transformed COX-2-ASA–derived 17R-hydroxy-DHA into two sets of novel di- and trihydroxy products; one initiated via oxygenation at carbon 7 and the other at carbon 4. These compounds inhibited (IC50 ∼50 pM) microglial cell cytokine expression and in vivo dermal inflammation and peritonitis at ng doses, reducing 40–80% leukocytic exudates. These results indicate that exudates, vascular, leukocytes and neural cells treated with aspirin convert DHA to novel 17R-hydroxy series of docosanoids that are potent regulators. These biosynthetic pathways utilize omega-3 DHA and EPA during multicellular events in resolution to produce a family of protective compounds, i.e., resolvins, that enhance proresolution status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233 · cited 7×
“Like other LO-derived eicosanoids, LXs are potent-local acting in subnanomolar levels with precise stereochemical requirements for evoking their actions (4, 9).”
BackgroundMethodInfluentialSelf-citation(1999) · PubMed · Cited by 2,062
Robbins pathologic basis of disease
Cotran, R. S., Kumar, V., & Collins, T. (1989) · Medical Entomology and Zoology · Cited by 1,944
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationMarchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationBlood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146 · cited 3×
“It is noteworthy that both patient groups received aspirin in the GISSI trial while comparing tocopherol versus omega-3 supplementation (20) as did a significant number of participants in the most recent Physician Health study report (18).”
Background
Research works printed but not linked: 1
- De Caterina, R., S. Endres, S.D. Kristensen, and E.B. Schmidt, editors. 1993. N-3 Fatty Acids and Vascular Disease. Springer-Verlag, London. pp. 1–166.
Cited by
Items 801–900 of 1,004
Pro-Resolving Ligands Orchestrate Phagocytosis
Decker, C., Sadhu, S., & Fredman, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660865 · Cited by 38
Inflammatory reaction – communication of cells
Terheyden, H., Stadlinger, B., Sanz, M., Garbe, A. I., & Meyle, J. (2013) · Clinical Oral Implants Research · doi:10.1111/clr.12176 · Cited by 38
Mattacks, C. A., Sadler, D., & Pond, C. M. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20041147 · Cited by 39
“The synthesis of such messenger molecules may be facilitated by diets enriched with oils such as sunflower-seed oil that contain a high proportion of n-6 PUFA.”
InfluentialMacrophages in Vascular Inflammation: Origins and Functions
Decano, J. L., Mattson, P. C., & Aikawa, M. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0585-2 · Cited by 37
Winkler, J. W., Libreros, S., de la Rosa, X., Sansbury, B. E., Norris, P. C., Chiang, N., Fichtner, D., Keyes, G. S., Wourms, N., Spite, M. R., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mi0617-254r · Cited by 37
Self-citationStereoselective synthesis of maresin 1
Tungen, J. E., Aursnes, M., & Hansen, T. V. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.02.080 · Cited by 35
Bioanalytical insights into mediator lipidomics
Kasuga, K., Suga, T., & Mano, N. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.02.011 · Cited by 37
Effects of dietary Docosahexaenoic, training and acute exercise on lipid mediators
Capó, X., Martorell, M., Sureda, A., Tur, J. A., & Pons, A. (2016) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-016-0126-y · Cited by 37
“neutrophils, preventing the infiltration of neutrophils into sites of inflammation, and RvD1 also inhibits IL1β production [34].”
BackgroundMurru, E., Carta, G., Cordeddu, L., Melis, M. P., Desogus, E., Ansar, H., Chilliard, Y., Ferlay, A., Stanton, C., Coakley, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061730 · Cited by 35
“A number of studies have provided strong evidence that the resolution of inflammation is a biosynthetically active process, regulated by biochemical mediators and receptor-dependent signaling pathways, driven by specialized pro-resolving mediators [23].”
BackgroundNeuroprotectin D1 Protects Against Postoperative Delirium-Like Behavior in Aged Mice
Zhou, Y., Wang, J., Li, X., Li, K., Chen, L., Zhang, Z., & Peng, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.582674 · Cited by 35
“NPD1 shares biological activities with other lipid mediators such as resolvins and maresins, including accelerating nonphlogistic macrophage phagocytosis, inhibiting neutrophil infiltration, and regulating the production of cytokines and chemokines (Serhan et al., 2002; Mukherjee et al., 2004; Hong et al., 2014).”
BackgroundDas, U. N. (2013) · Clinical Lipidology · doi:10.2217/clp.13.32 · Cited by 37
Resolvin D1 Reduces Infarct Size Through a Phosphoinositide 3-Kinase/Protein Kinase B Mechanism
Kim, G., Bernier, J., Bourque-Riel, V., Malick, M., & Rousseau, G. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000245 · Cited by 35
“Omega-3 polyunsaturated fatty acid (PUFA) metabolites, such as Resolvins, have recently been discovered to evoke proresolution with anti-inflammatory effects.(4,5) Resolvins of Series E (RvE) are derived from the omega-3 PUFA eicosapentaenoic acid (EPA), whereas Resolvins of Series D (RvD) originate from the omega-3 P…”
BackgroundFirst total synthesis of the anti-inflammatory lipid mediator Resolvin D6
Rodríguez, A. R., & Spur, B. W. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.11.003 · Cited by 35
Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase
Dobson, E. P., Barrow, C. J., Kralovec, J. A., & Adcock, J. L. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m036186 · Cited by 35
Can vagus nerve stimulation halt or ameliorate rheumatoid arthritis and lupus?
Das, U. N. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-19 · Cited by 35
“Torpedo electric organ slices also synthesize PGE2 from endogenous substrates.”
BackgroundInfluentialDavidson, E. P., Coppey, L. J., Shevalye, H., Obrosov, A. A., Kardon, R. H., & Yorek, M. A. (2017) · Cornea · doi:10.1097/ico.0000000000001182 · Cited by 35
Debris-stimulated tumor growth: a Pandora’s box?
Haak, V. M., Huang, S., & Panigrahy, D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09998-8 · Cited by 36
Fatty Acid Oxidation and Pro-Resolving Lipid Mediators Are Related to Male Infertility
Signorini, C., Moretti, E., Noto, D., Micheli, L., Ponchia, R., & Collodel, G. (2022) · Antioxidants · doi:10.3390/antiox11010107 · Cited by 34
“SPMs are formed by enzymatic oxygenation of polyunsaturated fatty acids (PUFAs) and are divided into families including lipoxins, resolvins, protectins, and maresins [6,7].”
BackgroundBannenberg, G. L. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.57 · Cited by 39
“RvE1 reduces neutrophilendothelial cell interactions and transmigration, stimulates nonphlogistic phagocytosis by macrophages, and reduces the release of proinflammatory cytokines[33,111,184,185,187,188,189,190,191].”
BackgroundInfluentialProresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review
Romano, M., Patruno, S., Pomilio, A., & Recchiuti, A. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0078 · Cited by 39
Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid
Hjorth, E., & Freund‐Levi, Y. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32835017cc · Cited by 36
“maresins [35], neuroprotectins [36], and resolvins [37].”
BackgroundMADERNA, P., & Godson, C. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.004 · Cited by 38
“[3] C.”
BackgroundInfluentialLipid Mediator Informatics and Proteomics in Inflammation-Resolution
Lu, Y., Hong, S., Gotlinger, K. H., & Serhan, C. N. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.118 · Cited by 35
“Bioactive members from DHA with conjugated triene structures are DTs that are immunoregulatory[ 8 ,13] and neuroprotective[15] and are termed protectins/neuroprotectins.”
BackgroundMethodInfluentialSelf-citationDevchand, P. R., Schmidt, B. A. R., Primo, V., Zhang, Q., Arnaout, M. A., Serhan, C. N., & Nikolic, B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2565com · Cited by 34
“Perhaps the most notable and enigmatic example is the effect of aspirin acetylation of Cox-2 protein on its ability to catalyze formation of potent lipid mediators (7, 8).”
BackgroundSelf-citationMaresin 1 attenuates pro‐inflammatory activation induced by β‐amyloid and stimulates its uptake
Wang, Y., Leppert, A., Tan, S., van der Gaag, B., Li, N., Schultzberg, M., & Hjorth, E. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16098 · Cited by 33
Costa, P., Reis-Canaan, J. C., Castelo, P. M., Fonseca, D. C., Pereira, S. M., Murata, R. M., Pardi, V., & Pereira, L. J. (2021) · Nutrients · doi:10.3390/nu13030973 · Cited by 37
Hampel, U., Krüger, M., Kunnen, C. M. E., Garreis, F., Willcox, M. D. P., & Paulsen, F. P. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.08.024 · Cited by 33
Das, U. N. (2013) · Clinical Lipidology · doi:10.2217/clp.13.31 · Cited by 33
Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study
Erdinest, N., Ovadia, H., Kormas, R. M., & Solomon, A. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-6 · Cited by 34
“The results of the study support previous studies which have shown that RVs are very potent [17,45].”
BackgroundResultLee, H.-J., Han, Y., An, J. M., Kang, E. A., Park, Y. J., Cha, J.-Y., & Hahm, K. B. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1524299 · Cited by 34
Tobón‐Arroyave, S. I., Isaza‐Guzmán, D. M., Gómez‐Ortega, J., & Flórez‐Alzate, A. A. (2019) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13173 · Cited by 33
Shay, A. E., Nshimiyimana, R., Samuelsson, B. O., Petasis, N. A., Haeggström, J. Z., & Serhan, C. N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116559118 · Cited by 33
Self-citationNandivada, P., Cowan, E. A., Carlson, S. J., Chang, M. I., Gura, K. M., & Puder, M. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.02.008 · Cited by 37
Anderson, P. O., & Delgado, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00387.x · Cited by 36
“The other resolvins, especially RvD1, inhibit TNF -induced IL-1 production by microglia, reduce PMN infiltration into inflamed brain, skin and peritoneum, and are protective in a model renal ischemic injury [141, 142, 153].”
BackgroundIntestinal responsiveness to experimental colitis in young rats is altered by maternal diet
Jacobson, K., Mundra, H. K., & Innis, S. M. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00459.2004 · Cited by 33
Resolvin D1 attenuates CCl 4 -induced acute liver injury involving up-regulation of HO-1 in mice
Chen, X., Gong, X., Jiang, R., Wang, B., Kuang, G., Li, K., & Wan, J. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1115517 · Cited by 35
Shu, Y., Liu, Y., Li, X., Cao, L., Yuan, X.-L., Li, W., & Cao, Q. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.088 · Cited by 34
“Specialized pro-resolving lipid mediators, such as lipoxin and resolving have the ability to prevent excessive neutrophil trafficking to inflammation sites and thereby promote damaged tissue recovery (Serhan et al., 2002; Spite et al., 2009; Wu et al., 2010).”
BackgroundSaban, D. R., Hodges, R. R., Mathew, R., Reyes, N. S., Chen, Y., Kaye, R., Swift, W., Botten, N., Serhan, C. N., & Dartt, D. A. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0089-1 · Cited by 33
Self-citationChen, Z.-S., Yu, M., Wang, K., Meng, X.-L., Liu, Y., Shou, S., & Chai, Y. (2022) · Nutrition · doi:10.1016/j.nut.2022.111886 · Cited by 32
Lecchi, C., Invernizzi, G., Agazzi, A., Modina, S., Sartorelli, P., Savoini, G., & Ceciliani, F. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.09.019 · Cited by 35
“Finally, both EPA and DHA give rise to a newly discovered family of anti-inflammatory mediators called resolvins (Serhan et al., 2002).”
BackgroundReinertsen, A. F., Primdahl, K. G., Shay, A. E., Serhan, C. N., Hansen, T. V., & Aursnes, M. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c02913 · Cited by 32
Self-citationMałachowa, N., Kobayashi, S. D., Quinn, M. T., & DeLeo, F. R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00259 · Cited by 33
“These lipid mediators promote recruitment of monocytes, efferocytosis of apoptotic neutrophils, uptake of debris, resolution of inflammation, and tissue regeneration (51, 52).”
BackgroundBreaking the cycle: the role of omega-3 polyunsaturated fatty acids in inflammation-driven cancers
Patterson, W. L., & Georgel, P. T. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2013-0127 · Cited by 34
“Serhan et al. (2002) demonstrated that the D-series resolvins blocked TNF-induced production of the inflammatory cytokine IL-1 .”
BackgroundImpact of DHA on Metabolic Diseases from Womb to Tomb
Arnoldussen, I. A. C., & Kiliaan, A. J. (2014) · Marine Drugs · doi:10.3390/md12126190 · Cited by 34
“DHA can be converted into potent novel molecules with anti-inflammatory and organ-protective properties [13–17] such as the specialized pro-resolving lipid mediators (SPMs), including D- and E-series resolvins, neuroprotectins, and maresins (Figure 1) [15–19] via specialized chemical mediators.”
BackgroundNutritional factors and aging in demyelinating diseases
Adamo, A. M. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0360-8 · Cited by 38
“…from PUFAs could have positive effects on the treatment of MS: Lipoxins might reduce inflammation by decreasing neutrophil activity (Yacoubian and Serhan 2007), while resolvins and protectins, derived from omega-3 PUFAs, seem to control inflammation in the nervous system (Serhan et al. 2002).”
BackgroundSerum amyloid P inhibits granulocyte adhesion
Maharjan, A., Roife, D., Brazill, D. T., & Gomer, R. H. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-2 · Cited by 32
Neuroprotectin D1 inhibits retinal ganglion cell death following axotomy
Qin, Q., Patil, K., Gronert, K., & Sharma, S. C. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.022 · Cited by 34
Self-citationMeesawatsom, P., Burston, J. J., Hathway, G. J., Bennett, A. J., & Chapman, V. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0676-6 · Cited by 39
“(Continued from previous page) 5-LOX, 5-Lipoxygenase; ANOVA, Analysis of variance; AP, Action potential; AT-RvD1, Aspirin-triggered resolvin D1; BOC-2, Butoxy carbonyl-Phe-Leu-Phe-Leu-Phe; cDNA, Complementary deoxyribonucleic acid; ChemR23, Chemerin receptor; COX-2, Cyclooxygenase-2; DHA, Docosahexaenoic acid; FLAP, 5…”
BackgroundInfluentialFriesen, R., & Innis, S. M. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00257.2005 · Cited by 36
“ARA and EPA are further metabolized to locally active autocoids collectively known as eicosanoids via the action of cyclooxygenases and lipoxygenases, whereas DHA can be further metabolized to docosanoids and other 22-carbon metabolites (6, 45).”
BackgroundAdvances in the Chemistry and Biology of Specialised Pro-Resolving Mediators (SPMs)
Byrne, L., & Guiry, P. J. (2024) · Molecules · doi:10.3390/molecules29102233 · Cited by 31
“However, RvD1 and RvE1 have been shown to block the action of cysteinyl leukotrienes by preventing the increase in Ca 2+ and thereby preventing the activation of the ERK1/2 receptor. recorded to inhibit physiological processes of in fl ammation, decrease neutrophil assembly and block cytokine production.”
BackgroundInfluentialKenchegowda, S., He, J., & Bazán, H. E. P. (2012) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.03.010 · Cited by 32
Hall, T. C., Bilku, D. K., Neal, C. P., Cooke, J., Fisk, H. L., Calder, P. C., & Dennison, A. R. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.07.001 · Cited by 34
Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting
Schmöcker, C., Zhang, I. W., Kiesler, S., Kassner, U., Ostermann, A. I., Steinhagen‐Thiessen, E., Schebb, N. H., & Weylandt, K. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010180 · Cited by 35
D‐series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution
Ganesan, R., Henkels, K. M., Shah, K. N., de la Rosa, X., Libreros, S., Cheemarla, N. R., Serhan, C. N., & Gómez-Cambronero, J. (2020) · The FASEB Journal · doi:10.1096/fj.201903025rr · Cited by 32
Self-citationArtru, F., McPhail, M. J. W., Triantafyllou, E., & Trovato, F. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867261 · Cited by 32
Molecular Pharmacology of Inflammation Resolution in Atherosclerosis
Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094808 · Cited by 34
“In a study evaluating the effect of lipoxin A4 on myocardial ischemia-reperfusion injury following cardiac arrest in a rabbit model, the inhibitory effect of LXA4 on NF-κB, IL1β, IL-6, and TNF-α expression, as well as the infarct ratio and apoptotic index values, was Int.”
BackgroundInfluentialImpact of health and lifestyle food supplements on periodontal tissues and health
Spahr, A., & Divnic‐Resnik, T. (2022) · Periodontology 2000 · doi:10.1111/prd.12455 · Cited by 35
Bioactive Oxylipins Profile in Marine Microalgae
Linares-Maurizi, A., Réversat, G., Awad, R., Bultel‐Poncé, V., Oger, C., Galano, J., Balas, L., Durbec, A., Bertrand‐Michel, J., Durand, T., et al. (2023) · Marine Drugs · doi:10.3390/md21030136 · Cited by 31
“The lipoxygenase-catalyzed derivatives of ALA, such as EPA (resolvins E) and DHA (resolvins D, protectins), have been reported to display anti-inflammatory properties [23] in nano and picomolar levels [24,25].”
BackgroundWales, K. M., Kavazos, K., Nataatmadja, M. I., Brooks, P. R., Williams, C., & Russell, F. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112816 · Cited by 31
“Since resolvin D1 is produced from DHA during an acute inflammatory challenge [19,20], we predicted that the combination of ApoE genetic background with infusion of angiotensin II would increase the plasma concentration of resolvin D1 if the mice were supplemented with the high n-3 PUFA diet.”
BackgroundInability to resolve specific infection generates innate immunodeficiency syndrome in Xiap−/− mice
Hsieh, W., Chuang, Y.-T., Chiang, I., Hsu, S., Miaw, S., & Lai, M. (2014) · Blood · doi:10.1182/blood-2014-03-564609 · Cited by 33
Therapeutic Targets for Management of Periodontitis and Diabetes
Sima, C., & Dyke, T. E. V. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160216150338 · Cited by 34
“RvEs were characterized and tested in vivo and in vitro demonstrating potent anti-inflammatory and pro-resolution properties [184].”
BackgroundAT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
Wang, C., Maruyama, C. L., Easley, J. T., Trump, B., & Baker, O. J. (2017) · Scientific Reports · doi:10.1038/srep45525 · Cited by 32
Soory, M. (2010) · Cancers · doi:10.3390/cancers2020670 · Cited by 31
Lipid mediators in neutrophil biology: inflammation, resolution and beyond
Ghodsi, A., Hidalgo, A., & Libreros, S. (2024) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000822 · Cited by 30
Eady, T. N., Khoutorova, L., Atkins, K. D., Bazan, N. G., & Belayev, L. (2012) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-4-19 · Cited by 31
Yorek, M. S., Obrosov, A. A., Shevalye, H., Coppey, L. J., Kardon, R. H., & Yorek, M. A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.022 · Cited by 30
Polyunsaturated Fatty Acid Metabolism in the Brain and Brain Cells
Joffre, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88232 · Cited by 34
Specialized pro-resolving mediators in diabetes: novel therapeutic strategies
Brennan, E. P., Mohan, M., Andrews, D. C., Bose, M., & Kantharidis, P. (2019) · Clinical Science · doi:10.1042/cs20190067 · Cited by 30
Resolvins: Potent Pain Inhibiting Lipid Mediators via Transient Receptor Potential Regulation
Roh, J., Go, E. J., Park, J., Kim, Y. H., & Park, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.584206 · Cited by 32
New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation
Camba-Gómez, M., Gualillo, O., & Conde, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052605 · Cited by 31
Dietary Control of Inflammation and Resolution
Sears, B., & Saha, A. K. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.709435 · Cited by 35
“These SPMs are biosynthesized from EPA, DHA, and docosapentaenoic acid (DPA) (35, 36).”
BackgroundDeng, J., Golub, L. M., Lee, H., Raja, V., Johnson, F., Kucine, A. J., Lee, W., Xu, T., & Gu, Y. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s330157 · Cited by 30
Resolvin E1 reduces hepatic fibrosis in mice with Schistosoma japonicum infection
Qiu, W., Guo, K., Yi, L., Gong, Y., Huang, L., & Zhong, W. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1641 · Cited by 30
Total Synthesis and Bioactivity of 18(R)-Hydroxyeicosapentaenoic Acid
Krishnamurthy, V. R., Dougherty, A., Haller, C. A., & Chaikof, E. L. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo2002243 · Cited by 30
Zambalde, É. P., Teixeira, M. M., Favarin, D. C., de Oliveira, J. R., Magalhães, M. L., Cunha, M. M., Silva, W. C., Okuma, C. H., Rodrigues, V., Levy, B. D., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.03.014 · Cited by 30
Medicines and Vegetable Oils as Hidden Causes of Cardiovascular Disease and Diabetes
Okuyama, H., Langsjoen, P. H., Ohara, N., Hashimoto, Y., Hamazaki, T., Yoshida, S., Kobayashi, T., & Langsjoen, A. M. (2016) · Pharmacology · doi:10.1159/000446704 · Cited by 36
Regulation of inflammation by lipid mediators in oral diseases
Sommakia, S., & Baker, O. J. (2016) · Oral Diseases · doi:10.1111/odi.12544 · Cited by 30
Fonseca, F. C. D. S., Orlando, R. M., Turchetti-Maia, R. M. M., & Francischi, J. N. (2017) · Journal of Inflammation Research · doi:10.2147/jir.s142424 · Cited by 30
Scarpati, M., Qi, Y., Govind, S., & Singh, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211897 · Cited by 31
Resolvin E1 and its precursor 18R-HEPE restore mitochondrial function in inflammation
Hecker, M., Sommer, N., Foch, S., Hecker, A., Hackstein, H., Witzenrath, M., Weißmann, N., Seeger, W., & Mayer, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.011 · Cited by 33
Berenbaum, F. (2004) · Joint Bone Spine · doi:10.1016/j.jbspin.2004.02.003 · Cited by 36
Vijay-Kumar, M., Vanegas, S. M., Patel, N., Aitken, J. D., Ziegler, T. R., & Ganji, V. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-16 · Cited by 29
Chen, S., Li, S., Kuang, C., Zhong, Y., Yang, Z., Yang, Y., & Liu, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1186384 · Cited by 32
“17(R)-hydroxy docosahexaenoic acid is derived from aspirin-acetylated cyclooxygenase-2 (COX-2) and can be converted to 17 R-RvD (Serhan et al., 2002).”
BackgroundHecker, M., Ott, J., Sondermann, C., Schaefer, M. B., Obert, M., Hecker, A., Morty, R. E., Vadász, I., Herold, S., Rosengarten, B., et al. (2014) · Critical Care · doi:10.1186/cc13850 · Cited by 31
Shinohara, M., & Serhan, C. N. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33928 · Cited by 31
Self-citationGala, K. S., & Vatsalya, V. (2020) · Cells · doi:10.3390/cells9030524 · Cited by 31
“Resolvins are lipid mediators derived from omega-3 polyunsaturated fatty acids (•3-PUFAs) like docosahexaenoic acid (DHA), n-3 docosapentaenoic acid (n-3 DPA) and eicosapentaenoic acid (EPA) that counter-regulate proinflammatory responses [116].”
BackgroundNanotherapeutics in the treatment of acute respiratory distress syndrome
Prasanna, P., Rathee, S., Upadhyay, A., & Sulakshana, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119428 · Cited by 29
Grossi, P., Bertoni, G., Piccioli-Cappelli, F., & Trevisi, E. (2013) · Journal of Animal Science · doi:10.2527/jas.2012-5661 · Cited by 35
Understanding Resolvin Signaling Pathways to Improve Oral Health
Keinan, D., Leigh, N. J., Nelson, J. W., Oleo, L. D., & Baker, O. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035501 · Cited by 31
“These lipid mediators were originally identified by Serhan and colleagues in a self-limited model of acute inflammation and have provided new insights indicating that resolution of inflammation is an active process [24,27].”
BackgroundInfluentialn-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial
Grenon, S. M., Owens, C. D., Alley, H. F., Chong, K. C., Yen, P. K., Harris, W. S., Hughes‐Fulford, M., & Conte, M. S. (2013) · Vascular Medicine · doi:10.1177/1358863x13503695 · Cited by 30
Yorek, M. S., Coppey, L. J., Shevalye, H., Obrosov, A. A., Kardon, R. H., & Yorek, M. A. (2016) · Journal of Nutrition and Metabolism · doi:10.1155/2016/5905891 · Cited by 29
“Our current understanding of lipid derived health benefits implicates proresolving lipid mediators, such as resolvin D1, as the major curative entity produced from the metabolism of EPA and DHA [10].”
BackgroundInfluentialFedirko, V., McKeown‐Eyssen, G., Serhan, C. N., Barry, E. L., Sandler, R. S., Figueiredo, J. C., Ahnen, D. J., Bresalier, R. S., Robertson, D. J., Anderson, C. W., et al. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22629 · Cited by 29
Self-citationWang, R. X., & Colgan, S. P. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.02.002 · Cited by 30
“Aspirin-triggered production of resolvins from EPA and DHA also occurs (Serhan et al., 2000a, 2002).”
BackgroundSelf-citationOrchestrating Role of Apoptosis Inhibitor of Macrophage in the Resolution of Acute Lung Injury
Kimura, H., Suzuki, M., Konno, S., Shindou, H., Shimizu, T., Nagase, T., Miyazaki, T., & Nishimura, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601798 · Cited by 31
“such as resolvin (8, 9), protectin (10), lipoxin (11), and maresin”
Profiling the regulatory lipids: another systemic way to unveil the biological mystery
Yang, J., Dong, H., & Hammock, B. D. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283468c10 · Cited by 35
Cell-Cell Interaction in the Transcellular Biosynthesis of Novel ω-3-Derived Lipid Mediators
Chiang, N., & Serhan, C. N. (2006) · Humana Press eBooks · doi:10.1385/1-59745-113-4:227 · Cited by 39
Self-citationPolyunsaturated fatty acids and peripheral artery disease
Grenon, S. M., Hughes‐Fulford, M., Rapp, J. H., & Conte, M. S. (2012) · Vascular Medicine · doi:10.1177/1358863x11429175 · Cited by 30
Duttaroy, A. K. (2016) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201500496 · Cited by 28
Roy, J., Vigor, C., Vercauteren, J., Réversat, G., Zhou, B., Surget, A., Larroquet, L., Lanuque, A., Sandres, F., Terrier, F., et al. (2020) · Biochimie · doi:10.1016/j.biochi.2020.06.010 · Cited by 28
Payrits, M., Horváth, Á. I., Biró-Sütő, T., Erostyák, J., Makkai, G., Sághy, É., Pohóczky, K., Kecskés, A., Kecskés, M., Szolcsányi, J., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145019 · Cited by 29
Metadata
- Authors
- Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-10-21
- Volume
- 196
- Issue
- 8
- Pages
- 1025-1037
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194036
- OpenAlex
- W2162465757
- Cited by
- 1,650
- References
- 62
- Citations by year
- 2026: 40 · 2025: 45 · 2024: 65 · 2023: 61 · 2022: 68 · 2021: 75 · 2020: 101 · 2019: 78 · 2018: 81 · 2017: 81 · 2016: 84 · 2015: 94 · 2014: 100 · 2013: 112 · 2012: 92
- FWCI
- 30.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (4r37gm038765-19, DE13499, GM 38765, P01-DE13499)
- National Institute of General Medical Sciences (GM 38765, R01GM038765, R37-GM038765)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- resolvins, aspirin, cyclooxygenase-2, docosahexaenoic acid, omega-3 fatty acids, inflammation resolution, microglia, neutrophils, eicosanoid biosynthesis, anti-inflammatory mediators, peritonitis, skin inflammation, leukocyte recruitment
- MeSH terms
- Animals, Aspirin, Biological Factors, Humans, Inflammation, Tumor Cells, Cultured, Signal Transduction, Fatty Acids, Omega-3, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.